RPCONE
EW icon

Retirement Planning Company of New England’s Edwards Lifesciences EW Stock Holding History

Retirement Planning Company of New England’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-750
Closed -$97K – 432
2021
Q4 		$97K Buy
+750
New +$87.5K 0.05% 308

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Retirement Planning Company of New England's EW Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 750 shares — an estimated $97K sold.

Retirement Planning Company of New England first reported a position in EW in Q4 2021 and held it in 1 quarter. The position peaked at $97K in Q4 2021. 1,315 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 750 Edwards Lifesciences shares in Q1 2022, an estimated $97K.
  • Retirement Planning Company of New England first reported a position in Edwards Lifesciences in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's Edwards Lifesciences position peaked at $97K in Q4 2021.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.